相關主題
商品描述
This book examines the progress in the biotechnology sector in India towards knowledge and innovation driven Bioeconomy. The chapters of the book review different genome editing techniques and the GM crops focusing on the emerging potential in agricultural biotechnology. Chapters on Vaccines and AI in healthcare unfold huge opportunities in medical biotechnology. The book covers the advances in biotechnology towards delivering important benefits of healthcare, particularly through the pharmaceutical industry focusing on new healthcare interventions and delivering innovations. Further, it explores the major opportunities in industrial biotechnology related to bio-pharma, biorefinery, fermentation biotechnology, and growing synergies between industry-academia. Toward the end, the book also reviews the genetic regulation and the critical role of HRD. In summary, the book emphasizes on India as a strong bio-manufacturing hub for innovative, affordable and accessible products for the society and also for global markets while describing the sector wise strategies required.
商品描述(中文翻譯)
本書探討了印度生物技術領域在知識和創新驅動的生物經濟方面的進展。書中的章節評論了不同的基因組編輯技術和轉基因作物，重點關注農業生物技術的新興潛力。關於疫苗和人工智能在醫療保健中的應用的章節揭示了醫學生物技術的巨大機遇。本書涵蓋了生物技術在提供重要的醫療保健福利方面的進展，特別是通過藥品行業關注新的醫療保健干預和創新的交付方式。此外，本書還探討了與生物製藥、生物煉製、發酵生物技術以及產業與學術界之間不斷增長的協同作用相關的工業生物技術的主要機遇。最後，本書還回顧了基因調控和人力資源發展的關鍵角色。總之，本書強調印度作為一個強大的生物製造中心，為社會和全球市場提供創新、負擔得起和可訪問的產品，同時描述了相應的行業戰略。
作者簡介
Dr. George John is a former Senior Advisor, Dept. of Biotechnology, Govt of India and former Vice Chancellor, Birsa Agricultural University, Ranchi. He has over 35 years of experience in various national and international organizations as a scientist, research manager, policy maker and institution builder. He has a Masters and a Ph.D from the University of Madras. He was a scientist in the Agricultural Research Service from 1978 to 1992, and later on in the Department of Biotechnology, Government of India from 1992 to 2013. He was the Vice Chancellor of Birsa Agricultural University, Ranchi from Sept 2014 to Sept 2016. He contributed to the areas of animal biotechnology, aquaculture, marine biotechnology, and public private partnership. He was a senior scientist at WorldFish (CGIAR), Cairo from 2001 to 2006. He was involved in various national and international committees and also in creation of a new institute of animal biotechnology. Dr. John implemented the Small Business Innovation Research Initiative (SBIRI) for promoting public-private partnership and bio-entrepreneurship. He has published about 50 papers in peer reviewed national and international journals and book chapters.
Dr. Amulya K. Panda worked at National Institute of Immunology, New Delhi from 1990 to 2021 and retired as its Director in May 2021. He is past president, Association of Microbiologists of India 2017, Member, Scientific Board of Pharmacopeia Commission of India (2021-2024) and Fellow of Royal Society of Chemistry (Cambridge) since 2020. He has a B. Tech degree from HBTI, Kanpur, Master's from IIT Madras and Ph D from IIT Delhi. He was a visiting scientist at the Dept. of Chemical Engineering, University of California at Berkeley, USA (1994). His area of expertise is in bioprocess engineering that includes fermentation, protein refolding, and formulation of biologicals using nanoparticles. Dr. Panda reported the highest amount of recombinant protein expression among the earliest Indian studies (1999). Novel protein refolding methods developed by him have been accepted worldwide for high throughput recovery of bioactive protein from inclusion bodies of E. coli (2005). He was awarded Young Asian Biotechnologist Prize from the Society for Biotechnology, Japan, for the year 2004. He has published 165 research papers, 12 book chapters and is an inventor of 35 patents. Currently he is Associate Director at Panacea Biotec Limited, New Delhi.
作者簡介(中文翻譯)
Dr. George John是印度政府生物技術部的前高級顧問和Birsa農業大學的前副校長。他在科學家、研究經理、政策制定者和機構建設者方面擁有超過35年的國內外組織經驗。他在馬德拉斯大學獲得碩士和博士學位。他曾在1978年至1992年期間擔任農業研究服務的科學家，之後在印度政府生物技術部從事工作，直到2013年。他於2014年9月至2016年9月擔任Birsa農業大學的副校長。他在動物生物技術、水產養殖、海洋生物技術和公私合作方面做出了貢獻。他曾在2001年至2006年期間擔任世界漁業中心（CGIAR）的高級科學家。他參與了各種國內外委員會的工作，並參與了一個新的動物生物技術研究所的建立。John博士實施了小型企業創新研究計劃（SBIRI），以促進公私合作和生物創業。他在國內外同行評審的期刊和專書中發表了約50篇論文。
Dr. Amulya K. Panda於1990年至2021年在印度新德里的國家免疫學研究所工作，並於2021年5月退休時擔任該所所長。他是2017年印度微生物學家協會的前主席，2021-2024年印度藥典委員會科學委員會的成員，並自2020年起是英國皇家化學學會（劍橋）的院士。他在HBTI, Kanpur獲得B. Tech學位，IIT Madras獲得碩士學位，並在IIT Delhi獲得博士學位。他曾是美國加州大學伯克利分校化學工程系的訪問科學家（1994年）。他的專業領域是生物過程工程，包括發酵、蛋白質重摺疊和使用納米粒子製備生物製劑。Panda博士報告了印度早期研究中最高的重組蛋白表達量（1999年）。他開發的新型蛋白質重摺疊方法已被全球接受，用於高通量從大腸桿菌的包涵體中回收生物活性蛋白質（2005年）。他於2004年獲得了日本生物技術學會頒發的亞洲青年生物技術學家獎。他發表了165篇研究論文，12篇專書章節，並擁有35項專利。目前，他是新德里Panacea Biotec Limited的副總監。
